Skip to main content

May 2018 (Supplement)

Perspectives
05/21/2018
Abstract: Adult acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. Distinct subtypes of AML have been defined based on morphology, immunophenotyping, and molecular genetics. AML usually progresses...
Abstract: Adult acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. Distinct subtypes of AML have been defined based on morphology, immunophenotyping, and molecular genetics. AML usually progresses...
...
05/21/2018
Journal of Clinical Pathways
Department
05/21/2018
JCP Editors
Last year, the Food and Drug Administration (FDA) approved a total of 46 drugs, tying a record set for approvals in 2015. Cancer medications accounted for the majority of these approvals, with 16 oncology and 11...
Last year, the Food and Drug Administration (FDA) approved a total of 46 drugs, tying a record set for approvals in 2015. Cancer medications accounted for the majority of these approvals, with 16 oncology and 11...
Last...
05/21/2018
Journal of Clinical Pathways

Department

Research in Review
05/21/2018
JCP Editors
Clearance of Somatic Mutations and the Effect on Risk of Relapse in AML Clearance of somatic mutation at complete remission is associated with significantly better survival in patients with acute myeloid...
Clearance of Somatic Mutations and the Effect on Risk of Relapse in AML Clearance of somatic mutation at complete remission is associated with significantly better survival in patients with acute myeloid...
...
05/21/2018
Journal of Clinical Pathways

Column

Editor's Page
05/21/2018
Acute myelogenous leukemia (AML) is a rapid progressing malignancy of the myeloid progenitor cells, characterized by an uncontrolled proliferation of primitive blast cells replacing normal bone marrow cells. It is...
Acute myelogenous leukemia (AML) is a rapid progressing malignancy of the myeloid progenitor cells, characterized by an uncontrolled proliferation of primitive blast cells replacing normal bone marrow cells. It is...
Acute...
05/21/2018
Journal of Clinical Pathways